methylene blue has been researched along with Shock, Cardiogenic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monas, J; Skolnik, A | 1 |
| Chen, F; Dalia, AA; Devine, LT; French, A; Kawabori, M; Ortoleva, J; Roberts, RJ; Shelton, K | 1 |
| Hoffman, RS; Jang, DH; Nelson, LS | 1 |
| Haouzi, P; Sonobe, T | 1 |
| Baldo, CF; Ceneviva, R; Evora, PR; Meirelles, RF; Viaro, F | 1 |
2 review(s) available for methylene blue and Shock, Cardiogenic
| Article | Year |
|---|---|
The Crashing Toxicology Patient.
Topics: Antidotes; Arrhythmias, Cardiac; Cardiotonic Agents; Chemical and Drug Induced Liver Injury; Continuous Renal Replacement Therapy; Emergency Service, Hospital; Extracorporeal Membrane Oxygenation; Fat Emulsions, Intravenous; Glucagon; Glucose; Hormones; Humans; Hypoglycemic Agents; Insulin; Methylene Blue; Poisoning; Respiratory Insufficiency; Resuscitation; Seizures; Shock, Cardiogenic; Sweetening Agents; Vasoconstrictor Agents | 2020 |
Methylene blue for distributive shock: a potential new use of an old antidote.
Topics: Anaphylaxis; Animals; Antidotes; Cyclic GMP; Drug Resistance; Endothelium, Vascular; Enzyme Inhibitors; Humans; Isoenzymes; Methylene Blue; Models, Biological; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Second Messenger Systems; Sepsis; Shock; Shock, Cardiogenic; Vascular Resistance | 2013 |
3 other study(ies) available for methylene blue and Shock, Cardiogenic
| Article | Year |
|---|---|
Methylene Blue for Vasoplegia During Extracorporeal Membrane Oxygenation Support.
Topics: Extracorporeal Membrane Oxygenation; Humans; Methylene Blue; Prospective Studies; Retrospective Studies; Shock, Cardiogenic; Vasoplegia | 2021 |
H2S induced coma and cardiogenic shock in the rat: Effects of phenothiazinium chromophores.
Topics: Animals; Antidotes; Azure Stains; Biotransformation; Cardiac Output; Cardiotonic Agents; Coma; Disease Models, Animal; Hydrogen Sulfide; Male; Methylene Blue; Phenothiazines; Rats, Sprague-Dawley; Shock, Cardiogenic; Structure-Activity Relationship; Sulfides; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2015 |
Methylene blue improves hemodynamic shock but increases lipoperoxidation in severe acute pancreatitis pig model.
Topics: Acute Disease; Animals; Biomarkers; Cholagogues and Choleretics; Disease Models, Animal; Drug Evaluation, Preclinical; Enteropeptidase; Enzyme Inhibitors; Hemodynamics; Lipid Peroxidation; Male; Malondialdehyde; Methylene Blue; Nitrates; Pancreatitis; Shock, Cardiogenic; Swine; Taurocholic Acid; Time Factors | 2008 |